ArticleBMC infectious diseases2025
Cervical conization and high risk - HPV status changes in relation to menopause: a retrospective longitudinal study based on generalized additive mixed models.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ectocervical margin involvement is associated with postoperative hrHPV positivity after hysterectomy or residual cervix resection for incompletely excised CIN3: a retrospective study.BMC women's health · 2026Article
- Innovations in HPV vaccination and their role in global cervical cancer control: a review.Therapeutic advances in vaccines and immunotherapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe relationship between high-risk human papillomavirus (HR-HPV) infection outcomes and cervical lesion recurrence after conization is well documented. However, the temporal dynamics of human papillomavirus (HPV) status post-conization, especially in postmenopausal women, remain unclear.
methodsThis retrospective cohort study consecutively enrolled 598 patients who underwent conization, all of whom had baseline HR-HPV positivity and histologically confirmed cervical intraepithelial neoplasia (CIN) 2-3. All patients had at least one follow - up HPV test after surgery. Temporal changes in HPV status following conization and their association with menopause were analyzed using Generalized Additive Mixed Models (GAMM).
resultsAmong the 598 patients, GAMM analysis revealed a significant decrease in HPV positivity risk over time. Adjusting for confounders, the overall risk of HPV positivity decreased by 59% every 4 months within the first 24 months post-conization (OR: 0.41, 95% CI: 0.35-0.47). After 24 months, the risk continued to decline by 7% every 4 months (OR: 0.93, 95% CI: 0.81-1.06). Menopause status significantly influenced these temporal changes; postmenopausal patients had a 45% increased risk of HPV positivity every 4 months after conization compared to premenopausal patients (OR: 1.45, 95% CI: 1.13-1.85), particularly within the first 24 months (p = 0.0032).
conclusionsIn patients undergoing conization, longitudinal HPV infection status changes were independently associated with menopause. The risk of HPV positivity decreased significantly in the first 24 months post-surgery, with a more pronounced decline in premenopausal patients, informing HPV testing strategies post-conization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.